| K2 | K2 One Step Synthetic Cannabis Test Device (Urine) | 50ng/ml, 30ng/ml |
| AMP | AMP One Step Amphetamine Test Device (Urine) | 1000ng/ml |
| BAR | BAR One Step Barbiturates Test Device (Urine) | 300ng/ml |
| BZO | BZO One Step Benzodiazepines Test Device (Urine) | 300ng/ml |
| BUP | BUP One Step Buprenorphine Test Device (Urine) | 10ng/ml |
| COC | COC One Step Cocaine Test Device (Urine) | 300ng/ml |
| COT | COT One Step Cotinine Test Device (Urine) | 200ng/ml |
| MDMA | MDMA One Step Ecstasy Test Device (Urine) | 500ng/ml |
| EDDP | EDDP One Step Test Device (Urine) | 100ng/ml |
| FYL | FYL One Step Fentanyl Test Device (Urine) | 200ng/ml |
| KET | KET One Step Ketamine Test Device (Urine) | 1000ng/ml |
| THC | THC One Step Marijuana Test Device (Urine) | 50ng/ml |
| MTD | MTD One Step Methadone Test Device (Urine) | 300ng/ml |
| MET | MET One Step Methamphetamine Test Device (Urine) | 1000ng/ml |
| MQL | MQL One Step Methaqualone Test Device (Urine) | 300ng/ml |
| MOP | MOP One Step Morphine Test Device (Urine) | 300ng/ml |
| OPI | OPI One Step Opiates Test Device (Urine) | 2000ng/ml |
| OXY | OXY One Step Oxycodone Test Device (Urine) | 100ng/ml |
| PCP | PCP One Step Phencyclidine Test Device (Urine) | 25ng/ml |
| PPX | PPX One Step Propoxyphene Test Device (Urine) | 300ng/ml |
| PGB | PGB One Step Pregabalin Test Device (Urine) | 300ng/ml |
| TCA | TCA One Step Tricyclic Antidepressants Test Device (Urine) | 1000ng/ml |
| TML | TML One Step Tramadol Test Device (Urine) | 100ng/ml |
| COC saliva | COC One Step Cocaine Test Device (saliva) | 20ng/ml |
| OPI saliva | OPI One Step Opiates Test Device (saliva) | 40ng/ml |
| MDMA saliva | MDMA One Step Ecstasy Test Device (saliva) | 50ng/ml |
| BZO saliva | BZO One Step Benzodiazepines Test Device (saliva) | 10ng/ml |
| AMP saliva | AMP One Step Amphetamine Test Device (Urine) | 50ng/ml |
| THC saliva | THC One Step Marijuana Test Device (saliva) | 25ng/ml |
● For professional in vitro diagnostic use only.
● Do not use after the expiration date indicated on the package. Do not use the test if the foil pouch is damaged. Do not reuse tests.
● This kit contains products of animal origin. Certified knowledge of the origin and/or sanitary state of the animals does not completely guarantee the absence of transmissible pathogenic agents. It is therefore, recommended that these products be treated as potentially infectious, and handled by observing usual safety precautions (e.g., do not ingest or inhale).
● Avoid cross-contamination of specimens by using a new specimen collection container for each specimen obtained.
● Read the entire procedure carefully prior to testing.
● Do not eat, drink or smoke in the area where specimens and kits are handled. Handle all specimens as if they contain infectious agents. Observe established precautions against microbiological hazards throughout the procedure and follow standard procedures for the proper disposal of specimens. Wear protective clothing such as laboratory coats, disposable gloves and eye protection when specimens are assayed.
● Humidity and temperature can adversely affect results.
● Discard used testing materials in accordance with local regulations.
Bring tests, specimens, and/or controls to room temperature (15-30°C or 59-86°F) before use.
1. Remove the test from its sealed pouch, and place it on a clean, level surface. Label the test with patient or control identification. For best results, the assay should be performed within one hour.
2. Take off the cap outside of the test end. With arrows pointing toward the urine specimen, immerse the test panel vertically into the urine specimen for at least 10-15 seconds. Immerse the test panel to at least the level of the wavy lines on the strip(s), do not pass the arrows on the test panel when immersing the panel.
3. Place the test panel on a non-absorbent flat surface, start the timer and wait for the red line(s) to appear. The results should be read at 5 minutes.Do not interpret results after 10 minutes.
Result：
Accuracy
The accuracy of the Rapid Response Drugs of Abuse Test Device was compared and checked against commercially available tests with a threshold value at the same cut-off levels. Urine samples taken from volunteers claiming to be non-users were examined under both tests. The results were >99.9% in agreement.
Reproducibility
The reproducibility of the Rapid Response Drugs of Abuse Test Device was verified by blind tests performed at four different locations. Samples with drug/metabolite concentrations at 50% of the cut-off were all determined to be negative, while samples
with drug/metabolite concentrations at 200% of the cut-off were all determined to be positive.
Precision
Test precision was determined by blind tests with control solutions. Controls with drug/metabolite concentrations at 50% of the cut-off yielded negative results, and controlswith drug/metabolite concentrations at 150% of the cut-off yielded positive results.
